Dermatol. praxi. 2009;3(2):63-66

Comorbidities in psoriasis - a new perspective of an old disease

doc. MUDr. Vladimír Vašků, CSc
Dermatovenerologická klinika, FN Brno

Psoriasis is multifactorial disease with manifestation on genetic background. The manifestation under provoking factors is the result of

many genes. There are some possible associations between psoriasis and comorbid conditions in this way. Psoriasis is driven by immune

mechanisms with important role of activated T lymphocytes and some factors of non specific immunity. Inflammation in psoriasis could

be connected i. e. with some cardiovascular diseases. Especially in severe psoriasis effective systemic treatment is necessary. Biologicals

are hopeful in this way.

Keywords: psoriasis, multigenic background, comorbidities, treatment.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vašků V, CSc. Comorbidities in psoriasis - a new perspective of an old disease. Dermatol. praxi. 2009;3(2):63-66.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vašků V. Etiopatogeneze psoriázy. In: Benáková, et al. Psoriáza nejen pro praxi. Praha: Triton, 2005: 47-58.
    2. Barker JN. Immune pathogenesis of psoriasis. Dermatol Today Tomorrow 1992; 27: 8-11.
    3. Bos JD, deRie MA, et al. Psoriasis dysregulation of innate imunity. Br J Derm 2005; 152: 1098-1107. Go to original source... Go to PubMed...
    4. Gulliver W. Long term prognosis in patiens with psoriasis. Br J Derm 2008; 159(Suppl. 2): 2-9. Go to original source... Go to PubMed...
    5. Spah F. Inflammation in atherosclerosis and psoriasis -common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Derm 2008; 159(Suppl. 2): 10-17. Go to original source... Go to PubMed...
    6. Camerin AJ, Shaw JE, Zimmet PZ. The metabolit syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-375. Go to original source... Go to PubMed...
    7. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolit syndrome in patiens with psoriasis: a hospital based casecontrol study. Br J Dermatol 2007; 157: 68-73. Go to original source... Go to PubMed...
    8. Mallbris L, Akre O, Granath F, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225-230. Go to original source... Go to PubMed...
    9. Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol, 2007; 157(4): 649-655. Go to original source... Go to PubMed...
    10. Gulliver WP. Importance of screening for comorbidities in psoriasi patients. Expert Rev Dermatol 2008; 3(2): 133-135. Go to original source...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.